UB Paderborn / Katalog / Suche / in CDI

Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners

PloS one, 2012-05, Vol.7 (5), p.e38335

2012

Link zum Volltext

Verfügbarkeit prüfen

HIV Risk and Interest in Preexposure Prophylaxis in Justice-Involved Persons

Emerging infectious diseases, 2024-04, Vol.30 (13), p.S68-S74

2024

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community

Addiction science & clinical practice, 2022-03, Vol.17 (1), p.15-15, Article 15

2022

Link zum Volltext

Verfügbarkeit prüfen

Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non-Clinicians

Psychiatric research and clinical practice, 2023-09, Vol.5 (3), p.78-83

2023

Link zum Volltext

Verfügbarkeit prüfen

Ending the HIV Epidemic for Persons Who Use Drugs: the Practical Challenges of Meeting People Where They Are

Journal of general internal medicine : JGIM, 2023-09, Vol.38 (12), p.2816-2818

Springer, Sandra A.

2023

Link zum Volltext

Verfügbarkeit prüfen

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV

Drug and alcohol dependence reports, 2023-06, Vol.7, p.100159-100159, Article 100159

2023

Link zum Volltext

Verfügbarkeit prüfen

Commentary on Murphy et al.: What will it take to prescribe extended‐release naltrexone to treat alcohol use disorder?

Addiction (Abingdon, England), 2022-02, Vol.117 (2), p.282-283

Springer, Sandra A.

2022

Link zum Volltext

Verfügbarkeit prüfen

Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons

BMC infectious diseases, 2022-04, Vol.22 (1), p.380-380, Article 380

2022

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Virus Reinfection Rate Among Persons Who Use Drugs and Are Maintained on Medication Treatment for Opioid Use Disorder

Clinical infectious diseases, 2020-06, Vol.70 (12), p.2703-2705

Springer, Sandra A

2020

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Antiretroviral Therapy among HIV-Infected Prisoners: Reincarceration and the Lack of Sustained Benefit after Release to the Community

Clinical infectious diseases, 2004-06, Vol.38 (12), p.1754-1760

2004

Link zum Volltext

Verfügbarkeit prüfen

Aortic Valve Surgery Outcomes Reporting and Implications for Persons Who Use Drugs With Infectious Endocarditis

Clinical infectious diseases, 2020-07, Vol.71 (3), p.488-490

Springer, Sandra A

2020

Link zum Volltext

Verfügbarkeit prüfen

Superiority of Directly Administered Antiretroviral Therapy over Self-Administered Therapy among HIV-Infected Drug Users: A Prospective, Randomized, Controlled Trial

Clinical infectious diseases, 2007-09, Vol.45 (6), p.770-778

2007

Link zum Volltext

Verfügbarkeit prüfen

Co-located Opioid Use Disorder and Hepatitis C Virus Treatment Is Not Only Right, But It Is Also the Smart Thing To Do as It Improves Outcomes

Clinical infectious diseases, 2020-10, Vol.71 (7), p.1723-1725

2020

Link zum Volltext

Verfügbarkeit prüfen

Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populations

BMC infectious diseases, 2019-10, Vol.19 (1), p.913-913, Article 913

2019

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone

Journal of substance abuse treatment, 2014-07, Vol.47 (1), p.35-40

2014

Link zum Volltext

Verfügbarkeit prüfen

Infectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases

Clinical infectious diseases, 2020-02, Vol.70 (5), p.968-972

2020

Link zum Volltext

Verfügbarkeit prüfen

Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans

Addiction science & clinical practice, 2022-01, Vol.17 (1), p.6-6, Article 6

2022

Link zum Volltext

Verfügbarkeit prüfen

HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study

The lancet HIV, 2014-11, Vol.1 (2), p.e77-e84

2014

Link zum Volltext

Verfügbarkeit prüfen

Integrating Treatment at the Intersection of Opioid Use Disorder and Infectious Disease Epidemics in Medical Settings: A Call for Action After a National Academies of Sciences, Engineering, and Medicine Workshop

Annals of internal medicine, 2018-09, Vol.169 (5), p.335

2018

Link zum Volltext

Verfügbarkeit prüfen

The Impact of DSM-IV Mental Disorders on Adherence to Combination Antiretroviral Therapy Among Adult Persons Living with HIV/AIDS: A Systematic Review

AIDS and behavior, 2012-11, Vol.16 (8), p.2119-2143

2012

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel

JAMA : the journal of the American Medical Association, 2023-01, Vol.329 (1), p.63

2023

Link zum Volltext

Verfügbarkeit prüfen

Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder

Contemporary clinical trials communications, 2021-03, Vol.21, p.100704-100704, Article 100704

2021

Link zum Volltext

Verfügbarkeit prüfen

Substance abuse, violence, and HIV in women: a literature review of the syndemic

Journal of women's health (Larchmont, N.Y. 2002), 2011-07, Vol.20 (7), p.991

2011

Link zum Volltext

Verfügbarkeit prüfen

Integrating Responses to the Opioid Use Disorder and Infectious Disease Epidemics: A Report From the National Academies of Sciences, Engineering, and Medicine

JAMA : the journal of the American Medical Association, 2020-07, Vol.324 (1), p.37

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners

HIV Risk and Interest in Preexposure Prophylaxis in Justice-Involved Persons

Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community

Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non-Clinicians

Ending the HIV Epidemic for Persons Who Use Drugs: the Practical Challenges of Meeting People Where They Are

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV

Risk behaviors and HIV care continuum outcomes among criminal justice-involved HIV-infected transgender women and cisgender men: Data from the Seek, Test, Treat, and Retain Harmonization Initiative

Commentary on Murphy et al.: What will it take to prescribe extended‐release naltrexone to treat alcohol use disorder?

Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons

Hepatitis C Virus Reinfection Rate Among Persons Who Use Drugs and Are Maintained on Medication Treatment for Opioid Use Disorder

Effectiveness of Antiretroviral Therapy among HIV-Infected Prisoners: Reincarceration and the Lack of Sustained Benefit after Release to the Community

Aortic Valve Surgery Outcomes Reporting and Implications for Persons Who Use Drugs With Infectious Endocarditis

Superiority of Directly Administered Antiretroviral Therapy over Self-Administered Therapy among HIV-Infected Drug Users: A Prospective, Randomized, Controlled Trial

Co-located Opioid Use Disorder and Hepatitis C Virus Treatment Is Not Only Right, But It Is Also the Smart Thing To Do as It Improves Outcomes

Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populations

An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone

Infectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases

Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans

HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study

Integrating Treatment at the Intersection of Opioid Use Disorder and Infectious Disease Epidemics in Medical Settings: A Call for Action After a National Academies of Sciences, Engineering, and Medicine Workshop

The Impact of DSM-IV Mental Disorders on Adherence to Combination Antiretroviral Therapy Among Adult Persons Living with HIV/AIDS: A Systematic Review

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel

Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder

Substance abuse, violence, and HIV in women: a literature review of the syndemic

Integrating Responses to the Opioid Use Disorder and Infectious Disease Epidemics: A Report From the National Academies of Sciences, Engineering, and Medicine

Suchergebnisse filtern